Search Results - "Tugçe Nur Yigenoglu"

Refine Results
  1. 1
  2. 2
  3. 3
  4. 4

    Is neutropenic fever an obstacle to effective stem cell harvesting? by Başcı, Semih, Bozan, Ersin, Yaman, Samet, Ulu, Bahar Uncu, Bakırtaş, Mehmet, Yiğenoğlu, Tuğçe Nur, Kılınç, Ali, Özcan, Nurgül, Dal, Mehmet Sinan, Çakar, Merih Kızıl, Altuntaş, Fevzi

    Published in Asian journal of transfusion science (01-01-2024)
    “…Autologous stem cell transplantation (ASCT) is a well-established consolidation treatment for many hematologic cancers which delivers prolonged survival. A…”
    Get full text
    Journal Article
  5. 5

    Peripheral stem cell mobilization strategies in patients with autologous hematopoietic cell transplantation: A single center's experience by NAMDAROĞLU, SİNEM, Yigenoglu, Tugçe Nur, Batgi, Hikmettullah, Uncu Ulu, Bahar, İskender, Dicle, Çakar, Merih, Dal, Mehmet Sinan, Altuntaş, Fevzi

    Published in Jurnal teknologi laboratorium (Online) (31-12-2020)
    “…This research is to investigate the parameters which may affect the mobilization of stem cells in patients receiving autologous hematopoietic peripheral blood…”
    Get full text
    Journal Article
  6. 6

    Extracorporeal blood purification treatment options for COVID-19: The role of immunoadsorption by Yiğenoğlu, Tuğçe Nur, Ulas, Turgay, Dal, Mehmet Sinan, Korkmaz, Serdal, Erkurt, Mehmet Ali, Altuntaş, Fevzi

    Published in Transfusion and apheresis science (01-08-2020)
    “…The activation of the innate and adaptive immune systems by SARS-CoV-2 causes the release of several inflammatory cytokines, including IL-6. The inflammatory…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Skin ulcers caused by ruxolitinib in a patient with chronic cutaneous graft-versus-host disease by Aslan Candır, Burcu, Yiğenoğlu, Tuğçe Nur, Kızıl Çakar, Merih, Dal, Mehmet Sinan, Altuntaş, Fevzi

    Published in Journal of oncology pharmacy practice (01-06-2022)
    “…Introduction Graft-versus-host disease (GVHD) is a common complication of allogeneic hematopoietic cell transplantation (HCT). In the treatment of chronic…”
    Get full text
    Journal Article
  9. 9

    Non hemorrhagic pericardial effusion from ibrutinib İn a patient without comorbidities by Aslan Candır, Burcu, Yiğenoğlu, Tuğçe Nur, Kızıl Çakar, Merih, Dal, Mehmet Sinan, Altuntaş, Fevzi

    Published in Journal of oncology pharmacy practice (01-06-2022)
    “…Introduction The most common kind of leukemia in adults is chronic lymphocytic leukemia (CLL). CLL is treated with ibrutinib. During the course of ibrutinib…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12
  13. 13

    An effective treatment in Erdheim Chester disease: vemurafenib: a case report by Bozan, Ersin, Darçin, Tahir, Yaman, Samet, YiÄenoÄlu, TuÄçe Nur, Kizil Çakar, Merih, Dal, Mehmet Sinan, AltuntaÅ, Fevzi

    Published in Journal of medical case reports (12-10-2023)
    “…Abstract Background Erdheim Chester disease (ECD) is a rare disease with multisystemic involvement in the group of non-langerhans cell histiocytosis. Although…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16

    Febrile neutropenia risk factors in actively treated diffuse large B-cell lymphoma patients by Mehmet Bakirtas, Tuğçe Nur Yiğenoğlu, Semih Başci, Bahar Uncu Ulu, Samet Yaman, Merih Kizil Çakar, Mehmet Sinan Dal, Fevzi Altuntaş

    Published in Iraqi Journal of Hematology (01-01-2022)
    “…BACKGROUND: Febrile neutropenia (FN) is a serious problem, especially in hematologic malignancies, and can cause high mortality rates and it occurs in 10%–20%…”
    Get full text
    Journal Article
  17. 17

    Face masks and polycythemia is the standard hemoglobin cutoff valid in the pandemic? by Samet Yaman, Semih Basci, Gökhan Turan, Bahar Uncu Ulu, Tugçe Nur Yigenoglu, Taha Bahsi, Haktan Bagis Erdem, Mehmet Sinan Dal, Merih Kizil Çakar, Fevzi Altuntas

    Published in Iraqi Journal of Hematology (01-07-2022)
    “…BACKGROUND: Polycythemia is a common reason for patients' admissions. With the introduction of COVID-19, face masks reached very common usage in the…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20

    Is the Optimal Timing First Complete Remission for Autologous Stem Cell Transplantation in Patients with Peripheral T-Cell Lymphoma? by UNCU ULU, Bahar, ŞAHİN, Derya, YİĞENOĞLU, Tuğçe Nur, KIZIL ÇAKAR, Merih, DAL, Mehmet Sinan, ALTUNTAŞ, Fevzi

    Published in Namık Kemal tıp dergisi (01-08-2021)
    “…Aim: Outcome for most patients with peripheral T-cell lymphomas (PTCLs) is poor, with low response rates and short durations of remission. We aim to analyze…”
    Get full text
    Journal Article